Aidan Crowley

Aidan Crowley

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2021 in Frontiers in Digital Health
Verified
Journal Article
Open access
KAKimberly R. Azelton
Kimberly R. Azelton
ACAidan Crowley
Aidan Crowley
NVNicholas Vence
Nicholas Vence
KUKarin Underwood
Karin Underwood
GMGerald Morris
Gerald Morris
Matthew J LandryMatthew J Landry
Matthew J Landry
Digital health coaching is an intervention for type 2 diabetes mellitus (T2DM) that has potential to improve the quality of care for patients. Previous research has established the efficacy of digital interventions for behavior change. This pilot study addresses a research gap in finding effective and accessible behavioral interventions for under-resourced individuals with T2DM. We examined the impact of Healthy at Home, a 12-week phone and SMS-based (short message service) digital health coaching program, on insulin resistance which is an upstream marker for T2DM progression. We compared this intervention to usual diabetic care in a family medicine residency clinic in a randomized controlled trial. Digital health coaching significantly improved participants' calculated Homeostatic Model Assessment for Insulin Resistance (HOMA2-IR) by −0.9 ± 0.4 compared with the control group (p = 0.029). This significance remained after controlling for years diagnosed with T2DM, enrollment in Medicaid, access to food, baseline stage of change, and race (p = 0.027). Increasing access to digital health coaching may lead to more effective control of diabetes for under-resourced patients. This study demonstrates the potential to implement a personalized, scalable, and effective digital health intervention to treat and manage T2DM through a lifestyle and behavioral approach to improve clinical outcomes (http://clinicaltrials.gov, NCT04872647).

1 April 2021 in Cytotherapy
Verified
Journal Article
Closed access
CSCambray Smith
Cambray Smith
ACAidan Crowley
Aidan Crowley
MMMegan Munsie
Megan Munsie
EDErin S. DeMartino
Erin S. DeMartino
NSNathan P. Staff
Nathan P. Staff
ZMZubin Master
Zubin Master

1 December 2021 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
CSCambray Smith
Cambray Smith
ACAidan Crowley
Aidan Crowley
MMMegan Munsie
Megan Munsie
ABAtta Behfar
Atta Behfar
EDErin S. DeMartino
Erin S. DeMartino
ZMZubin Master
Zubin Master

31 August 2020 in Journal of Renal Care
Verified
Journal Article
Closed access
PDF file
JFJeanette Finderup
Jeanette Finderup
ACAidan Crowley
Aidan Crowley
HSHenning Søndergaard
Henning Søndergaard
KLKirsten Lomborg
Kirsten Lomborg

1 December 2020 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
ZMZubin Master
Zubin Master
ACAidan Crowley
Aidan Crowley
CSCambray Smith
Cambray Smith
DWDennis Wigle
Dennis Wigle
ATAndre Terzic
Andre Terzic
RSRichard R. Sharp
Richard R. Sharp
The stem cell preservation industry has grown substantially with private businesses, public hospitals, and academic medical centers considering preserving induced pluripotent stem cells, mesenchymal stem cells, and other cell types of patients and the public in order to potentially use them for stem cell therapy should such an intervention exist in the future. Despite this growth and interest among private firms and academic centers, no study has yet considered the bioethical issues of such platforms. In this article, we explore several ethical and social issues related to the biopreservation of stem cells for future regenerative therapies. We analyze a range of bioethical considerations that public and private institutions should bear in mind as they develop stem cell preservation platforms. These include medical validation of regenerative interventions and their influence on the public understanding of stem cell therapies, the impact of public trust of organizations creating a private, for-profit venture of stem cell preservation, and logistical issues in the governance of the collection including ownership and dispositional authority, informed consent and access, and withdrawal and non-payment. These considerations should be incorporated into current and future stem cell preservation platforms in order to promote the responsible translation of regenerative medicine.

9 April 2023 in Academic Emergency Medicine
Verified
Journal Article
Closed access
ACAidan Crowley
Aidan Crowley
CSChuxuan Sun
Chuxuan Sun
XYXiaowei (Sherry) Yan
Xiaowei (Sherry) Yan
ANAmol Navathe
Amol Navathe
JLJoshua M. Liao
Joshua M. Liao
MDM. Kit Delgado
M. Kit Delgado